New Amsterdam Sciences Overview
- Founded
- 2012
- Status
- Out of Business
- Latest Deal Type
- Out of Business
New Amsterdam Sciences General Information
Description
Developer of anti-idiopathic pulmonary fibrosis drug created for the treatment of influenza infection, solid tumors and wound healing. The company's activities are engaged in the research, development and licensing of small molecule antioxidant SOD mimetics and peptide analogues for treatment of idiopathic pulmonary fibrosis, influenza infection, wound healing and solid tumors
Contact Information
Website
www.newamsterdamsciences.com
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 14362 North Frank Lloyd Wright Boulevard
- Suite 1000
- Scottsdale, AZ 85260
- United States
+1 (480) 000-0000
New Amsterdam Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 22-Mar-2020 | Completed | Out of Business | |||
| 2. Angel (individual) | 19-Nov-2015 | 00000 | Completed | Startup | ||
| 1. Grant | 11-Mar-2014 | Completed | Startup |
New Amsterdam Sciences Patents
New Amsterdam Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170065663-A1 | Substance and method for treating influenza | Abandoned | 02-May-2014 | 0000000000 |